文献速递肝病

全球一般人群中晚期肝纤维化与肝硬化的患病率:系统综述与Meta分析

Global Prevalence of Advanced Liver Fibrosis and Cirrhosis in the General Population: A Systematic Review and Meta-analysis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2024-08-30

全球晚期肝纤维化汇总患病率为3.3%(95%CI 2.4%-4.2%),肝硬化为1.3%(95%CI 0.9%-1.7%);2016年后两者患病率均呈上升趋势(晚期纤维化P=.004,肝硬化P=.034),且存在显著地域差异(P<.0001)。

要点

  • 全球一般人群晚期肝纤维化患病率为3.3%(95%CI 2.4%-4.2%),肝硬化为1.3%(95%CI 0.9%-1.7%)。
  • 2016年后晚期肝纤维化(P=.004)与肝硬化(P=.034)患病率均呈上升趋势。
  • 肝硬化潜在危险因素包括病毒性肝炎、糖尿病、过量饮酒、肥胖和男性。

核心结论

  • 全球晚期肝纤维化和肝硬化患病率相当高且呈上升趋势,并存在显著地域差异。
  • 需要进一步研究以更好地了解危险因素及如何在全球范围内减轻这些因素,以应对日益增长的全球肝硬化负担。

研究设计与样本

  • 系统综述与Meta分析,检索Embase、PubMed、Scopus和Web of Science自建库至2024年4月30日,无语言限制。
  • 纳入报告一般人群(年龄≥18岁、样本量至少100人)中晚期肝纤维化和/或肝硬化患病率的横断面研究,肝硬化受试者归入晚期纤维化组。
  • 采用随机效应模型估计汇总患病率及95%置信区间。

主要发现

  • 全球一般人群晚期肝纤维化汇总患病率为3.3%(95%CI 2.4%-4.2%)。
  • 全球一般人群肝硬化汇总患病率为1.3%(95%CI 0.9%-1.7%)。
  • 2016年后晚期纤维化(P=.004)和肝硬化(P=.034)患病率呈上升趋势。
  • 晚期纤维化和肝硬化患病率在大洲和国家层面存在显著地域差异(P<.0001)。
  • 肝硬化的潜在危险因素包括病毒性肝炎、糖尿病、过量饮酒、肥胖和男性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Limited data exist regarding the estimate of the prevalence of advanced liver fibrosis and cirrhosis in the general population. Therefore, we conducted a systematic review and meta-analysis to evaluate the global prevalence and risk factors of advanced fibrosis and cirrhosis. METHODS: We searched Embase, PubMed, Scopus, and Web of Science from inception to April 30 2024, with no language restriction. We included cross-sectional studies reporting the prevalence of advanced liver fibrosis and/or cirrhosis in a sample of at least 100 individuals aged ≥18 years from the general population. Subjects with cirrhosis were included in the advanced fibrosis group. The pooled prevalence proportions utilizing a random-effects model and 95% confidence intervals (CIs) were estimated using global data. RESULTS: A total of 46 studies fulfilled the eligibility criteria, comprising approximately 8 million participants from 21 countries. The pooled prevalence rates of advanced liver fibrosis and cirrhosis in the general population were 3.3% (95% CI, 2.4%-4.2%) and 1.3% (95% CI, 0.9%-1.7%) worldwide, respectively. A trend was observed for an increase in the prevalence of advanced fibrosis (P = .004) and cirrhosis (P = .034) after 2016. There were significant geographic variations in the advanced fibrosis and cirrhosis prevalence at continental and national levels (P < .0001). Potential risk factors for cirrhosis were viral hepatitis, diabetes, excessive alcohol intake, obesity, and male sex. CONCLUSIONS: The prevalence of advanced fibrosis and cirrhosis is considerable and increasing worldwide with significant geographic variation. Further research is needed to better understand the risk factors and how to mitigate them worldwide to address the growing global burden of cirrhosis.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Zamani M, Alizadeh-Tabari S, Ajmera V, et al. Global Prevalence of Advanced Liver Fibrosis and Cirrhosis in the General Population: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2024. PMID: 39209202. doi:10.1016/j.cgh.2024.08.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。